Post-approval studies (Phase 4)Ended earlyNCT00796705
What this trial is testing
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
Who this might be right for
Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID) 13